The field of thoracic oncology has undergone a significant transformation with the integration of next-generation genomic profiling technologies.

Over the past decade, advances in cancer genetics and oncogenomic have profoundly reshaped our understanding of pediatric tumors. Unlike adult cancers, ...

Breast cancer precision care is accelerating via giredestrant data, ADC sequencing, and NGS/ctDNA-driven targeting, while EMR ...

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...

Eight Researchers Named Fellows of the American Association for the Advancement of Science Rutgers faculty elected to the ...

Stratus Compute: Bionano Genomics, Inc.’s hardware/software upgrade that enables higher-throughput analysis for OGM workflows ...

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

Metastasis, the spread of cancer from a primary tumor to other parts of the body, is difficult to study in the lab, in part ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings ...

Clinically, I trained as a radiation oncologist, but since the start of my career I've had a faculty role, cross-appointed ...

In this article, we will look at the 10 best diagnostics and research stocks to buy according to analysts. The diagnostics ...

Liquid biopsies are expanding: Blood tests that can detect cancer are moving beyond just late-stage treatment selection. They ...